These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19755422)

  • 1. Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.
    Bowerman NA; Colf LA; Garcia KC; Kranz DM
    J Biol Chem; 2009 Nov; 284(47):32551-61. PubMed ID: 19755422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.
    Jones LL; Colf LA; Bankovich AJ; Stone JD; Gao YG; Chan CM; Huang RH; Garcia KC; Kranz DM
    Biochemistry; 2008 Nov; 47(47):12398-408. PubMed ID: 18973345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.
    Bowerman NA; Crofts TS; Chlewicki L; Do P; Baker BM; Christopher Garcia K; Kranz DM
    Mol Immunol; 2009 Sep; 46(15):3000-8. PubMed ID: 19595460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells.
    Hornell TM; Martin SM; Myers NB; Connolly JM
    J Immunol; 2001 Oct; 167(8):4207-14. PubMed ID: 11591741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation.
    Jones LL; Colf LA; Stone JD; Garcia KC; Kranz DM
    J Immunol; 2008 Nov; 181(9):6255-64. PubMed ID: 18941216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor.
    Schlueter CJ; Manning TC; Schodin BA; Kranz DM
    J Immunol; 1996 Nov; 157(10):4478-85. PubMed ID: 8906825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent cytolytic response by a CD8+ CTL clone to multiple peptides from the same protein in association with an allogeneic class I MHC molecule.
    Kageyama S; Tsomides TJ; Fukusen N; Papayannopoulos IA; Eisen HN; Sykulev Y
    J Immunol; 2001 Mar; 166(5):3028-34. PubMed ID: 11207252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.
    Brophy SE; Jones LL; Holler PD; Kranz DM
    Mol Immunol; 2007 Mar; 44(9):2184-94. PubMed ID: 17169430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How a single T cell receptor recognizes both self and foreign MHC.
    Colf LA; Bankovich AJ; Hanick NA; Bowerman NA; Jones LL; Kranz DM; Garcia KC
    Cell; 2007 Apr; 129(1):135-46. PubMed ID: 17418792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.
    Hawse WF; De S; Greenwood AI; Nicholson LK; Zajicek J; Kovrigin EL; Kranz DM; Garcia KC; Baker BM
    J Immunol; 2014 Mar; 192(6):2885-91. PubMed ID: 24523505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity.
    Engels B; Chervin AS; Sant AJ; Kranz DM; Schreiber H
    Mol Ther; 2012 Mar; 20(3):652-60. PubMed ID: 22233579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes.
    Lee PU; Churchill HR; Daniels M; Jameson SC; Kranz DM
    J Exp Med; 2000 Apr; 191(8):1355-64. PubMed ID: 10770802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural interactions between T cell receptors and MHC-peptide complexes place physical limits on self-nonself discrimination.
    Wucherpfennig KW
    Curr Top Microbiol Immunol; 2005; 296():19-37. PubMed ID: 16329190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism.
    Baker BM; Scott DR; Blevins SJ; Hawse WF
    Immunol Rev; 2012 Nov; 250(1):10-31. PubMed ID: 23046120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
    Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
    J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of peptide residues interacting with MHC molecule or T cell receptor. Can a peptide bind in more than one way to the same MHC molecule?
    Kurata A; Berzofsky JA
    J Immunol; 1990 Jun; 144(12):4526-35. PubMed ID: 2141038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.
    Sykulev Y; Brunmark A; Tsomides TJ; Kageyama S; Jackson M; Peterson PA; Eisen HN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11487-91. PubMed ID: 7972089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor.
    Stone JD; Chervin AS; Schreiber H; Kranz DM
    Biotechnol Prog; 2012; 28(6):1588-97. PubMed ID: 22961781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.